LAVAL, QC and CAMBRIDGE, England, Sept. 19, 2023 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), is pleased to announce that it received the final ...
LAVAL, QC and CAMBRIDGE, England, Aug. 16, 2023 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), announced today that the Ontario Superior Court of ...
Shareholders of Liminal BioSciences with questions regarding the Arrangement or the Meeting or requiring assistance with voting at the Meeting should contact Carson Proxy Advisors, the Company's proxy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback